2016 – FSHD Global provides funding for Dr Jean Mah to conduct a study into infantile FSHD, that is FSHD that effects children and adolescents. This study is providing valuable insight into the differences between FSHD that occurs in adulthood and FSHD that occurs in children.

FSHD Global provides funding to Dr Yi-Wen Chen to investigate the potential of new antisense oligonucleotides as a treatment for FSHD.